ICAGEN Trademark

Trademark Overview

On Tuesday, May 24, 2022, a trademark application was filed for ICAGEN with the United States Patent and Trademark Office. The USPTO has given the ICAGEN trademark a serial number of 97426304. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2024. This trademark is owned by Icagen, LLC. The ICAGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; Drug discovery services; Medical research; Pharmaceutical research and development
icagen

General Information

Serial Number97426304
Word MarkICAGEN
Filing DateTuesday, May 24, 2022
Status700 - REGISTERED
Status DateTuesday, October 8, 2024
Registration Number7531138
Registration DateTuesday, October 8, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Description of MarkThe mark consists of the wording "ICAGEN" with a spiral design around the center of the "A" where the horizontal line would normally appear. The "A" is the color orange and the rest of the mark is the color gray.
Indication of Colors claimedThe color(s) orange and gray is/are claimed as a feature of the mark.
Goods and ServicesBiological research; Drug discovery services; Medical research; Pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 31, 2022
Primary Code042
First Use Anywhere DateFriday, November 4, 2022
First Use In Commerce DateFriday, November 4, 2022

Trademark Owner History

Party NameIcagen, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 94608
Party NameIcagen, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 94608
Party NameIcagen, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Thursday, February 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 27, 2022NEW APPLICATION ENTERED
Tuesday, May 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 1, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, March 11, 2023ASSIGNED TO EXAMINER
Saturday, March 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2023USE AMENDMENT FILED
Tuesday, November 14, 2023TEAS STATEMENT OF USE RECEIVED
Monday, November 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 27, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 20, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 20, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 6, 2024SU - FINAL REFUSAL - WRITTEN
Wednesday, March 6, 2024FINAL REFUSAL E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 28, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 29, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 29, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 29, 2024ASSIGNED TO LIE
Tuesday, October 8, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 8, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

icagen research pharmaceutical development medical discovery drug biological services